Senior Director, Immuno-Oncology, US Marketing Strategy, @
Harvard Business School
Michael K. Lyons is a 15-year healthcare professional (11 years Specialty Oncology) with expertise in Marketing, Payer & Access, and Sales in the USA, Japan, Europe and Asia. He is serving his 4th consecutive international assignment with Eli Lilly & Company as a Chief Marketing Officer in Asia with focus on 3 imminent oncology launches and Lilly's
Michael K. Lyons is a 15-year healthcare professional (11 years Specialty Oncology) with expertise in Marketing, Payer & Access, and Sales in the USA, Japan, Europe and Asia. He is serving his 4th consecutive international assignment with Eli Lilly & Company as a Chief Marketing Officer in Asia with focus on 3 imminent oncology launches and Lilly's oncology portfolio.
At Lilly, Michael was selected as the 1st International Service Employee (expatriate) at Lilly Oncology Japan, where he led Japan's launch of CYRAMZA®, a forecasted 1 bUSD oncology affiliate brand; served as Japan's Oncology Innovation Leader that directed the teams of New Product Planning (Phase I-III), Brand, Public Policy; reversed Japan's oncology brand v. generic SOM erosion by 75%; created Japan's 1st Account Management organization; and created Japan's 1st pharmaceutical social media footprint. As Director of Thailand, he led Thai affiliate +9% oncology, +4% portfolio growth. In US & EU (2008-12), he launched and managed ALIMTA®, a 3 bUSD oncology brand.
He has received Lilly's highest honors including President's Council (USA), President's Award (Japan), Marketing Excel Award (both in USA & in Japan), Coach Of The Year (Japan) finalist, Director's Council (USA) and 4-time recipient of peer-nominated Models The Values Award (USA).
Michael earned a MBA from the Kellogg School of Management at Northwestern University, Certificates from Harvard Business School, Duke University, New York University, and a Bachelor Degree from the University at Albany.
He served several leadership roles with American Chamber of Commerce; is a recipient of Indiana's Citizen Energy Community Leader Award; and is the author of Amazon's 2014 Top 10% Best Seller, "SAME SAME: Marketing Basics from the Streets of Bangkok", which all the profits endow the "Chenoa and Michael K. Lyons Scholarship for the Sons and Daughters of Law Enforcement", a fund to help the children of America's Finest afford college tuition.
Chief Marketing Officer, Eli Lilly & Company, Asia @ Chief Marketing Officer with regional executive responsibility of an 9-affiliate marketing organization representing the 10 largest molecules in Lilly’s product portfolio of oncology, diabetes, bio-medicines, and muscular skeleton brands.
Lead multiple countries in multiple simultaneous world class launches.
Executive Officer with marketing scope over annual Business Plans and Customer Plans.
Exceed sales expectations through patent and generic challenges, and governmental opportunities.
Build and develop marketers and their capabilities into world class marketing organization. From August 2015 to Present (5 months) Innovation & Capability Leader (Oncology), Lilly Japan @ Led commercial oncology pipeline for Phase III, Phase II, Phase I assets (6 molecules, 13 indications) with at least 1 molecule launch every two years until 2020, including multiple indication launches in next 36 months. Directed dedicated teams of project leaders who are in close collaboration with Market Access, Global R&D teams, Oncology Medical Affairs and Medical Affairs Director.
Led Lilly’s Oncology’s policy program for patient access to new molecule assets. By partnering with governmental bodies, regulators, KOLs, and Advocacy groups, we encourage public policies and health care decisions that speed the progress of R&D, development of new medicines, assure cancer treatments respond to the needs and qualities of individual patients and improve patient access to the most effective cancer medicines.
Created and led 50 mUSD affiliate Brand and field-based Strategic Account Management teams that fully integrate commercial responsibilities for marketed products in 7 solid tumors (Pancreas, Biliary, Breast, Ovarian, Lung, Lymphoma, Urothelial). Maximized legacy product's sales by driving adoption in Pancreas and Biliary Tract Cancer; organized effective generic defense that grew branded product (that is 3 years post-patent loss) 5% during 2H 2014 in a fierce 100% generic market. In addition, slowed the branded erosion SOM .50% by reversing hospital generic switch. From September 2014 to July 2015 (11 months) Launch Leader, Lilly Japan (Oncology) @ Created and led launch platform for approval of CYRAMZA®, future blockbuster with peak/5th year forecast of 1 bUSD for Japan Affiliate. Accomplished launch readiness by directing strong cross-functional launch leadership with Marketing, Medical, Pricing, Sales, Global Team, and Regulatory. From January 2014 to August 2014 (8 months) Director, Lilly Thailand @ Marketing and Sales Leadership responsibility.
Reversed a 3-year slumping affiliate into a regional powerhouse. Led the Lilly portfolio (100 mUSD/71 people) to a 9% Oncology growth and 3.5% Corporate growth in just 7-months. Implemented strong national KOL engagement across country that drove growth, kept focus, and reduced OPEX. From July 2013 to January 2014 (7 months) Global Brand Strategy Manager, Lilly Global (Oncology) @ Led ALIMTA®, a $3 bUSD brand's (#6 oncology product worldwide) life-cycle management, including international branding, pricing, management of Global KOLs, market research.
Brand management over European, Asian, Australian marketplaces and payer systems. From November 2010 to June 2013 (2 years 8 months) US Brand Strategy Manager, Lilly USA (Oncology) @ Launch responsibility for two ALIMTA® indication launches (Lung Cancer:1st-line and Maintenance) into the US oncology marketplace, now worldwide NSCLC stand of care. Developed marketing analytics of customer segmentation analysis and implementation, reimbursement, access partners, KOLs, and sales force. From October 2008 to November 2010 (2 years 2 months) Executive Sales Specialist (Oncology) @ Led territory to the Top 1% of Lilly Oncology results for both revenue and percent to quota.
Develop strong Key Opinion Leader relationships with regional and national thought leaders.
#1 ranked Oncology Sales Person in United States. From January 2006 to October 2008 (2 years 10 months) District Sales Manager (Interim) @ Leadership and District Sales Management (Interim) supervising sales opportunity. From March 2005 to January 2006 (11 months) Hospital Account Based Sales Specialist (Neuroscience) @ Director's Council and National Sales Leadership Award-winning account-based sales results.
Launch and formulary approval experience for five new Lilly Neuroscience brands.
#1 ranked Neuroscience Sales Person in United States. From August 2001 to February 2005 (3 years 7 months) Creative Manager @ As a Creative Manager at Y&R, I partnered on the management of the Colgate Total toothpaste launch, as well as, the creative direction of Jell-O, Pepperidge Farms, Sony, Toblerone, and Phillip Morris's anti-smoking campaigns. Responsibilities included client pitch, strategic vision, art & copy. From May 1999 to January 2000 (9 months)
Master of Business Administration (M.B.A.), Business @ Northwestern University - Kellogg School of Management From 2011 to 2013 Duke Global Health Institute @ Duke UniversityHarvard Business School @ Harvard UniversitySchool of Humanities @ New York UniversityBachelor of Arts (B.A.), Writing and Critical Inquiry; Business @ University at Albany, SUNY Michael Lyons is skilled in: Oncology, Pharmaceutical Industry, Pharmaceutical Sales, Market Access, Global Marketing, Hospitals, Sales Effectiveness, Hospital Sales, Healthcare, Product Launch, Managed Care, Marketing Strategy, Cross-functional Team Leadership, Neuroscience, Urology
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension